tiprankstipranks
CANbridge Pharmaceuticals Inc. (HK:1228)
:1228
Hong Kong Market
1228
CANbridge Pharmaceuticals Inc.
RESEARCH TOOLSreports
Want to see HK:1228 full AI Analyst Report?

CANbridge Pharmaceuticals Inc. (1228) Financial Statements

0 Followers

CANbridge Pharmaceuticals Inc. Financial Overview

CANbridge Pharmaceuticals Inc.'s market cap is currently HK$1.28B. The company's EPS TTM is HK$-0.32; its P/E ratio is ―; CANbridge Pharmaceuticals Inc. is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 48.69M¥ 85.10M¥ 102.87M¥ 78.97M¥ 31.16M
Gross Profit¥ 35.68M¥ 54.30M¥ 64.16M¥ 48.89M¥ 18.78M
Operating Income¥ -90.30M¥ -340.51M¥ -366.55M¥ -457.97M¥ -655.15M
EBITDA¥ -78.47M¥ -328.69M¥ -341.43M¥ -454.63M¥ -1.06B
Net Income¥ 14.43M¥ -442.62M¥ -378.84M¥ -483.48M¥ -1.08B
Balance Sheet
Cash & Short-Term Investments¥ 66.65M¥ 10.50M¥ 137.49M¥ 451.16M¥ 745.82M
Total Assets¥ 165.46M¥ 116.81M¥ 395.36M¥ 702.04M¥ 892.52M
Total Debt¥ 16.09M¥ 135.78M¥ 141.93M¥ 155.28M¥ 52.10M
Net Debt¥ -50.56M¥ 125.28M¥ 17.03M¥ -295.88M¥ -693.71M
Total Liabilities¥ 507.36M¥ 591.30M¥ 435.15M¥ 393.49M¥ 199.13M
Stockholders' Equity¥ -341.90M¥ -474.49M¥ -39.79M¥ 308.56M¥ 693.39M
Cash Flow
Free Cash Flow¥ -38.22M¥ -122.50M¥ -319.09M¥ -315.76M¥ -592.40M
Operating Cash Flow¥ -38.21M¥ -122.39M¥ -278.23M¥ -280.98M¥ -587.07M
Investing Cash Flow¥ 1.23M¥ 13.93M¥ -26.86M¥ -34.79M¥ 126.09M
Financing Cash Flow¥ 92.47M¥ -18.57M¥ -28.02M¥ -20.70M¥ 854.31M
Currency in CNY

CANbridge Pharmaceuticals Inc. Earnings and Revenue History

Income Statement >

CANbridge Pharmaceuticals Inc. Debt to Assets

Balance Sheet >

CANbridge Pharmaceuticals Inc. Cash Flow

Cash Flow >

CANbridge Pharmaceuticals Inc. Forecast EPS vs Actual EPS

Earnings >